Opinion|Videos|April 1, 2025
Best Practices for Overcoming mCRC Prior Authorization Barriers
Experts discuss effective strategies for navigating the prior authorization process to ensure timely access to third-line therapies for metastatic colorectal cancer (mCRC) and share any success stories.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What strategies have you found effective in navigating the prior authorization process to ensure timely access to third-line therapies, and can you share any success stories?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns
2
5 Ongoing Phase 3 Trials in Hematologic Malignancies
3
CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps
4
ACE Inhibitors Linked to Reduced Mortality in Patients with Idiopathic Pulmonary Fibrosis
5
